Newsfeeds - Spark Newswire

3 minute read

Mid-Afternoon Market Update: Dow Falls 200 Points; Connect Biopharma Shares Tumble

Today, 11:10 AM

Toward the end of trading Friday, the Dow traded down 0.58% to 35,664.58 while the NASDAQ rose 0.53% to 16,078.19. The S&P also rose, gaining 0.05% to 4,706.69.

AVDX

3 minute read

Mid-Day Market Update: Crude Oil Down Over 4%; UWM Holdings Shares Surge

By Lisa Levin

Today, 11:10 AM

Midway through trading Friday, the Dow traded down 0.62% to 35,648.81 while the NASDAQ rose 0.53% to 16,078.23. The S&P also fell, dropping 0.01% to 4,704.35.

AVDX

3 minute read

Mid-Morning Market Update: Markets Mixed; Foot Locker Profit Beats Views

By Lisa Levin

Today, 11:10 AM

Following the market opening Friday, the Dow traded down 0.66% to 35,634.40 while the NASDAQ rose 0.54% to 16,079.51. The S&P also fell, dropping 0.03% to 4,703.27.

AUR

5 minute read

54 Biggest Movers From Yesterday

By Lisa Levin

Today, 11:10 AM

Gainers Longeveron Inc. (NASDAQ: LGVN) shares climbed 135.3% to close at $6.87 on Thursday. Longeveron said the FDA granted rare pediatric disease designation for the company’s Lomecel-B for the treatment of hypoplastic left heart syndrome.

AEHR

3 minute read

Mid-Afternoon Market Update: Dow Falls 75 Points; Dicerna Pharmaceuticals Shares Spike Higher

By Lisa Levin

Today, 11:10 AM

Toward the end of trading Thursday, the Dow traded down 0.21% to 35,855.96 while the NASDAQ rose 0.16% to 15,946.49. The S&P also rose, gaining 0.19% to 4,697.80.

ASYS

1 minute read

EXCLUSIVE: Longeveron CEO, Geoff Green & Co-Founder And Chief Scientific Officer, Dr. Josh Hare Now Interviewing On Benzinga’s Live Tv

By Zoltan Suranyi

Today, 11:10 AM

Click To Tune In Here....https://www.youtube.com/watch?v=77gGai0gpvE

LGVN

4 minute read

44 Stocks Moving In Thursday’s Mid-Day Session

By Lisa Levin

Today, 11:10 AM

Gainers Longeveron Inc. (NASDAQ: LGVN) jumped 157% to $7.51. Longeveron said the FDA granted rare pediatric disease designation for the company’s Lomecel-B for the treatment of hypoplastic left heart syndrome.

AEHR

1 minute read

Why Are Longeveron Shares Skyrocketing On Thursday?

By Vandana Singh

Today, 11:10 AM

The FDA has granted Rare Pediatric Disease (RPD) designation for Longeveron Inc’s (NASDAQ:LGVN) Lomecel-B for Hypoplastic Left Heart Syndrome (HLHS). HLHS is…

LGVN

4 minute read

Earnings Scheduled For November 12, 2021

By Benzinga Insights

Today, 11:10 AM

Companies Reporting Before The Bell • Zevia (NYSE:ZVIA) is estimated to report quarterly loss at $0.43 per share on revenue of $34.40 million.

AZN

1 minute read

2 Penny Stocks Insiders Are Buying

By Lisa Levin

Today, 11:10 AM

When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.

LGVN